Literature DB >> 1597853

A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.

K R Gustafson1, J H Cardellina, J B McMahon, R J Gulakowski, J Ishitoya, Z Szallasi, N E Lewin, P M Blumberg, O S Weislow, J A Beutler.   

Abstract

Extracts of Homalanthus nutans, a plant used in Samoan herbal medicine, exhibited potent activity in an in vitro, tetrazolium-based assay which detects the inhibition of the cytopathic effects of human immunodeficiency virus (HIV-1). The active constituent was identified as prostratin, a relatively polar 12-deoxyphorbol ester. Noncytotoxic concentrations of prostratin from greater than or equal to 0.1 to greater than 25 microM protected T-lymphoblastoid CEM-SS and C-8166 cells from the killing effects of HIV-1. Cytoprotective concentrations of prostratin greater than or equal to 1 microM essentially stopped virus reproduction in these cell lines, as well as in the human monocytic cell line U937 and in freshly isolated human monocyte/macrophage cultures. Prostratin bound to and activated protein kinase C in vitro in CEM-SS cells and elicited other biochemical effects typical of phorbol esters in C3H10T1/2 cells; however, the compound does not appear to be a tumor promoter. In skin of CD-1 mice, high doses of prostratin induced ornithine decarboxylase only to 25-30% of the levels induced by typical phorbol esters at doses 1/30 or less than that used for prostratin, produced kinetics of edema formation characteristic of the nonpromoting 12-deoxyphorbol 13-phenylacetate, and failed to induce the acute or chronic hyperplasias typically caused by tumor-promoting phorbols at doses of 1/100 or less than that used for prostratin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597853     DOI: 10.1021/jm00089a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  40 in total

1.  Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.

Authors:  Elizabeth J Beans; Dennis Fournogerakis; Carolyn Gauntlett; Lars V Heumann; Rainer Kramer; Matthew D Marsden; Danielle Murray; Tae-Wook Chun; Jerome A Zack; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-28       Impact factor: 11.205

2.  Making the most of Papua New Guinea's biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in "The Land of the Unexpected"

Authors:  L R Barrows; T K Matainaho; C M Ireland; S Miller; G T Carter; T Bugni; P Rai; O Gideon; B Manoka; P Piskaut; R Banka; R Kiapranis; J N Noro; C D Pond; C D Andjelic; M Koch; M K Harper; E Powan; A R Pole; J B Jensen
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

3.  How Might We Cure HIV?

Authors:  David M Margolis
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

4.  Inhibitors of Signaling Pathways That Block Reversal of HIV-1 Latency.

Authors:  Benni Vargas; Nicholas S Giacobbi; Anwesha Sanyal; Narasimhan J Venkatachari; Feng Han; Phalguni Gupta; Nicolas Sluis-Cremer
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

5.  Medicinal chemistry: Forcing an enemy into the open.

Authors:  Christian Melander; David M Margolis
Journal:  Nat Chem       Date:  2012-09       Impact factor: 24.427

6.  Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.

Authors:  Paul A Wender; Jung-Min Kee; Jeffrey M Warrington
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

7.  Isolation, structure determination, and anti-HIV evaluation of tigliane-type diterpenes and biflavonoid from Stellera chamaejasme.

Authors:  Yoshihisa Asada; Aya Sukemori; Takashi Watanabe; Kuber J Malla; Takafumi Yoshikawa; Wei Li; Xinzhu Kuang; Kazuo Koike; Chin-Ho Chen; Toshiyuki Akiyama; Keduo Qian; Kyoko Nakagawa-Goto; Susan L Morris-Natschke; Yan Lu; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2013-04-23       Impact factor: 4.050

8.  Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

Authors:  Sophie Reuse; Miriam Calao; Kabamba Kabeya; Allan Guiguen; Jean-Stéphane Gatot; Vincent Quivy; Caroline Vanhulle; Aurélia Lamine; Dolores Vaira; Dominique Demonte; Valérie Martinelli; Emmanuelle Veithen; Thomas Cherrier; Véronique Avettand; Solène Poutrel; Jacques Piette; Yvan de Launoit; Michel Moutschen; Arsène Burny; Christine Rouzioux; Stéphane De Wit; Georges Herbein; Olivier Rohr; Yves Collette; Olivier Lambotte; Nathan Clumeck; Carine Van Lint
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

Review 9.  Emerging strategies to deplete the HIV reservoir.

Authors:  Nancie M Archin; David M Margolis
Journal:  Curr Opin Infect Dis       Date:  2014-02       Impact factor: 4.915

10.  Variability in content of the anti-AIDS drug candidate prostratin in Samoan populations of Homalanthus nutans.

Authors:  Holly E Johnson; Sandra A Banack; Paul Alan Cox
Journal:  J Nat Prod       Date:  2008-12       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.